# Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

> **NCT01238809** · — · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 7300 (estimated)

## Conditions studied

- Self-administered Questionnaire to Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01238809
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-06
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 7300 (ESTIMATED)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238809, "Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01238809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*